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1. Introduction 
According to results of previous ~vestigations the 
catecholamines isoproterenol and dopamine induce in 
the rat myocardium an enhancement of glucose-6- 
phosphate dehydrogenase activity (EC 1 .l l.49) and 
an elevation of the available pool of S-phosphoribosyl- 
1-pyrophosphate (PRPP), one of the endproducts of 
the hexose monophosphate shunt [ 11. These findings 
indicated that catecholamines stimulate the myo- 
P 
cardial hexose monophosphate shunt apart from their 
well-known effect on glycogenolysis [2-41. Since 
only glucosed-phosphate d hydrogenase, the first 
and rate-l~it~g enzyme of the oxidative branch of 
this shunt [5] showed a marked response to 
catecholamines, it was of interest o examine the 
mechanism that may be responsible for this stimula- 
tion. 
Essentially two experimental pproaches were 
utilized to study this question: 
1. The time course of the i~proterenol-educed 
alterations in glucose&phosphate d hydrogenase 
activity was examined and compared to that of the 
changes in adenosine 3’$-monophosphate (CAMP) 
levels and in protein synthesis. Both parameters 
have been shown to be enhanced by catecholamines 
[2-4,6]. 
2. The effect of cycloheximide on the isoproterenol- 
induced enhancement of cardiac glucose-tj- 
phosphate dehydrogenase activity was studied. 
The results reported in this paper suggest that an 
increased new synthesis of enzyme protein is involved 
in bringing about the enhancement of glucose-6- 
phosphate dehydrogenase activity in the rat heart 
under the influence of isoproterenol. 
2. Materials and methods 
All experiments were done on female Sprague- 
Dawley rats (200-220 g bgdy wt) maintained on a 
standard iet of Altromin with free access to water. 
Isoproterenol was obtained from Fluka GmbH, Neu- 
Ulm, the &receptor blocking agent atenolol was a gift 
from ICI-Pharma, Heidelberg. Cycloheximide was 
purchased from Sigma Chemie, Mtinchen, [1-‘4C]- 
glycine (spec. act. 58 mCi/mmol) from Amersham 
Buchler, Braunschweig. Isoproterenol was injected 
subcutaneously in a dose of 25 mg/kg either alone or 
sim~t~eously with atenolol(2 mgfkg). Cyclo- 
heximide was administered intraperitoneally 6 h prior 
to the application of isoproterenol as well as 6 and 
12 h thereafter (0.6 mg/kg, respectively). 
In experiments in which cardiac CAMP levels were 
to be determined, the animals were anesthetized with 
diethyl ether at different times after administration 
of isoproterenol, and the hearts were rapidly removed 
after thoracotomy and immersed in Freon@ at 
-156*C. When the activity of glucose-6-phosphate 
dehydrogenase was to be measured, the rats 
anesthetized with diethyl ether were thoracotomized, 
a cannula was inserted into the ascending aorta, placed 
just above the aortic valve and tightly fixed. The 
hearts were rapidly excised, and the coronary arteries 
were purfused with ice-cold KC1 solution (0.15 M 
containing 8ml 0.02 M KHCO$l) to stop beating and 
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to remove blood. In experiments designed to evaluate 
protein synthesis, the animals were injected 
intravenously with [ l-14C]glycine (0.25 mCi/kg). 
After an exposure time of 60 min the hearts were 
rapidly excised and immersed in liquid nitrogen. 
Myocardial CAMP was determined by the methods 
in [7]. The procedures for homogenisation f the 
hearts, centrifugation, dialysis of the supernatants 
and measurement of glucose-6-phosphate dehydro- 
genase activity were essentially those reported [8,9] . 
Protein concentration i  the dialysate was determined 
using the modified biuret reaction [lo]. The specific 
activity of glucose8-phosphate d hydrogenase was 
expressed as units/g protein. Relative rates of cardiac 
protein synthesis were calculated by relating the 
radioacti~ty of total myocardial proteins to the mean 
specific activity of the intracellular glycine by the 
methods in [I 11. The data on protein synthesis were 
expressed as percentage of the control values. 
3. Results 
Figure 1 shows the effects of isoproterenol n 
myocardial CAMP, on cardiac protein synthesis and 
on ~ucose-6-phosphate dehydrogenase activity. 
CAMP was maximally enhanced already within 1 h of 
isoproterenol administration and dropped to baseline 
levels after 12 h (fig.lA). Protein synthesis was 
increased after 5 h reaching maximal stimulation 
after 12 h (fig.1 B). The activity of glucosed-phosphate 
dehydrogenase howed the first response to isopro- 
terenol after I2 h and attained the maximal increase 
after 48 h (fig,lC). 
Figure 2 demonstrates that the enhancement of 
glucose-6-phosphate dehydrogenase activity seen after 
24 h (fig.lC) was almost completely prevented when 
the P-receptor blocker atenolol was applied simulta- 
neously with isoproterenol. Cycloheximide did also 
Fig.2. Myo~~i glu~se~-phosphate dehydrogenase activity 
24 h after subcutaneous administration of i~proterenol 
either alone or in combination with atenolol or cyclo- 
heximide. Atenolol was applied subcutaneously at the same 
time as isoproterenol. Cycloheximide was administered intra- 
peritoneally 6 h prior to isoproterenol application (0.6 mg/ 
kg) and 6 and 12 h thereafter (0.6 mg/kg, respectively). Mean 
values 4 SEM, number of experiments in parentheses. 
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Fig.1. Effects of isoproterenol(25 mg/kg, administered 
subcutaneously) on CAMP levels, protein synthesis and 
glucose&phosphate dehydrogenase activity in rat hearts. 
Mean values f SEM, number of experiments in parentheses. 
I21 
i 
CONTROt 
*AlENU_fi cvuWExIMKK 
f2mg/kg,sc 1 WJmg/kg.lp 
kg,s.c.) 1 
Volume 106, number 2 FEBS LETTERS October 1979 
markedly attenuate the isoproterenolinduced stimula- 
tion of ~u~ose-6-phosphate dehy~rogenase activity. 
It did not affect the enzyme activity when given 
alone (data not shown). 
4, Discussion 
From the time course of changes given in fig.1 it is 
evident hat glucose-&phosphate dehydrogenase 
activity increased with a considerable time lag. It 
seemed therefore reasonable to assume that some 
metabolic processes, probably protein synthesis, must 
be enhanced in order to bring about this stimulation 
in our experimental condition. In fact, isoproterenol 
caused an e~ancement of protein synthesis [6] that 
occurred prior to the increase in glucose-6.phosphate 
dehydrogenase activity. Moreover, cycloheximide 
which bfocks protein synthesis at the translational 
ieve [ 12,131 and which prevented the isoproterenol- 
induced elevation of protein synthesis (data not 
shown), markedly attenuated ~ucose-6-phosphate 
dehydrogenase timulation (fig.2). From these results 
it appears that this enhancement is mainly due to 
increased new synthesis of enzyme protein. 
From the time-dependent al erations presented in 
fig.1 it is furthermore vident hat the elevation of 
CAMP is clearly the first event hat occurred 
immediately after stimulation of cardiac P-adrenergic 
receptors with isoproterenof. When this effect was 
antagonized by &receptor blockade with atenolol 
(fig.2) the stimulation of cardiac glucose-6.phosphate 
dehydrogenase activity was prevented. Thus it may be 
concluded that the enhancement of glucosed- 
phosphate dehydrogenase activity is mediated via 
cardiac &receptors and that CAMP is involved in 
bringing about the enhancement of protein synthesis 
and eventually of glucose-6.phosphate dehydrogenase. 
Although the mechanisms involved are not known, 
it is tempting to speculate that isoproterenol may 
affect RNA synthesis via stimulation of nuclear 
protein (histone and nor&stone) phosphorylation 
through the CAMP-dependent protein kinase system 
[ 141 thus resulting in increased synthesis of glucose- 
6-phosphate dehydrogenase. Such a sequence of 
events would eventually lead to stimulation of the 
hexose monophosphate shunt and thus contribute to 
keep the available pool of PRPP elevated. The 
sustained increase of the available PRPP pool can be 
considered to be responsible for the rn~nten~~e of
the enhanced purine biosynthesis which has been 
shown to occur under the influence of isoproterenol 
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